An open-label study of the effect of Roferon-A [interferon alpha-2a] plus ribavirin (Copegus) on safety and tolerability in patients with chronic hepatitis C viral infection.
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Interferon alpha-2a; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Roche
- 23 Mar 2008 Status changed from in progress to completetd, from Roche record.
- 20 Jun 2006 New trial record.